1. Home
  2. BATRK vs SLNO Comparison

BATRK vs SLNO Comparison

Compare BATRK & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series C

BATRK

Atlanta Braves Holdings Inc. Series C

HOLD

Current Price

$40.32

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$42.23

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRK
SLNO
Founded
1991
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BATRK
SLNO
Price
$40.32
$42.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$58.00
$110.90
AVG Volume (30 Days)
329.5K
1.6M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$723,307,000.00
$98,675,000.00
Revenue This Year
$12.40
N/A
Revenue Next Year
$6.78
$155.86
P/E Ratio
N/A
N/A
Revenue Growth
6.62
N/A
52 Week Low
$35.46
$39.43
52 Week High
$47.18
$90.32

Technical Indicators

Market Signals
Indicator
BATRK
SLNO
Relative Strength Index (RSI) 57.57 36.70
Support Level $39.71 $39.43
Resistance Level $40.62 $50.88
Average True Range (ATR) 0.69 2.79
MACD 0.05 -0.24
Stochastic Oscillator 74.29 26.46

Price Performance

Historical Comparison
BATRK
SLNO

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: